Phenex Pharmaceuticals AG
About Phenex Pharmaceuticals
Phenex Pharmaceuticals AG was founded in 2002. It is a privately owned drug discovery & development company based in the Biotech Cluster Rhine-Neckar in Heidelberg. Our company focuses its small-molecule drug discovery expertise in Liver diseases and in Cancer. Our aim is to translate novel scientific findings into best-in-class therapies that change current therapeutic regimens. The most advanced novel drug, Cilofexor, is currently in phase 2 clinical development by Gilead Sciences, to whom we sold this program in 2014.
Facts about Phenex Pharmaceuticals
Facts about Phenex Pharmaceuticals
- Focus : Manufacturer
- Industry : Pharma
News about Phenex Pharmaceuticals
Here you will find Phenex Pharmaceuticals AG
Last viewed contents
Lauterbach Verfahrenstechnik - Eggenstein, Germany
Myelodysplastic syndromes (MDS) linked to abnormal stem cells - Findings could yield therapies against these serious blood diseases and related cancers
Management changes at Accovion GmbH
VDE Verband der Elektrotechnik Elektronik Informationstechnik e.V. - Frankfurt am Main, Germany
Researchers use sugar to halt esophageal cancer in its tracks
De Novo Pharmaceuticals announces a Drug Discovery Partnership agreement with Achaogen
Pornthip_Rojanasunand
Cenix BioScience Delivers on Target Discovery Collaboration
LBF Industrietechnik GmbH - Lauterbach, Germany
First human antibodies to reach Alzheimer's target - Roche and MorphoSys announce major milestone in research collaboration
Biotech's Getting Back on Track - G. Steven Burrill's 18th Annual Report on the biotech industry's released
